Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Cumberland Pharmaceuticals (CPIX) Accumulated Depreciation & Amortization (2016 - 2025)

Cumberland Pharmaceuticals' Accumulated Depreciation & Amortization history spans 15 years, with the latest figure at $4.1 million for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 15.45% year-over-year to $4.1 million; the TTM value through Dec 2025 reached $4.1 million, down 15.45%, while the annual FY2025 figure was $4.1 million, 15.45% down from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $4.1 million at Cumberland Pharmaceuticals, down from $4.9 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.3 million in Q4 2022 and bottomed at $4.1 million in Q4 2025.
  • The 4-year median for Accumulated Depreciation & Amortization is $4.8 million (2021), against an average of $4.7 million.
  • The largest annual shift saw Accumulated Depreciation & Amortization grew 15.67% in 2022 before it decreased 15.45% in 2025.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $4.6 million in 2021, then grew by 15.67% to $5.3 million in 2022, then fell by 7.99% to $4.9 million in 2024, then fell by 15.45% to $4.1 million in 2025.
  • Per Business Quant, the three most recent readings for CPIX's Accumulated Depreciation & Amortization are $4.1 million (Q4 2025), $4.9 million (Q4 2024), and $5.3 million (Q4 2022).